Glycoprotein IX: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
(One intermediate revision by the same user not shown)
Line 22: Line 22:
[[Category:Platelet membrane glycoproteins]]
[[Category:Platelet membrane glycoproteins]]
{{medicine-stub}}
{{medicine-stub}}
{{No image}}
__NOINDEX__

Latest revision as of 13:33, 17 March 2025

Glycoprotein IX (GP IX) is a small platelet membrane glycoprotein that forms a 1-to-1 noncovalent complex with glycoprotein Ib (GP Ib), which is a component of the GP Ib-IX-V complex. GP IX, synthesized in megakaryocytes, circulates in the plasma as part of the GP Ib-IX-V complex, which is crucial for platelet adhesion to the subendothelium.

Structure[edit]

GP IX is a single-pass type I membrane protein. It interacts with glycoprotein Ib alpha and glycoprotein Ib beta to form a complex that is critical for platelet adhesion to the vascular endothelium. The GP Ib-IX-V complex binds to von Willebrand factor, allowing platelet adhesion and aggregation at sites of vascular injury.

Function[edit]

The primary function of GP IX is to contribute to the stability of the GP Ib-IX-V complex. This complex is essential for the process of platelet aggregation, which is a crucial step in the formation of a hemostatic plug during the process of blood coagulation.

Clinical significance[edit]

Mutations in the GP IX gene can lead to Bernard-Soulier syndrome, a rare disorder characterized by thrombocytopenia, giant platelets, and a bleeding tendency.

See also[edit]

References[edit]

<references />

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!